SALT LAKE CITY--(BUSINESS WIRE)--SignPath Pharma, Inc. reported in the March issue of Anticancer Research* that its proprietary intravenous liposomal curcumin (LipoCurc™) concentrates very intensely ...
Cancer is a life-threatening disease, leading to millions of fatalities every year. While advances in medical science have improved the prognosis significantly in the 21st century, it is still one of ...
Proteolysis Targeting Chimeras (PROTACs) are a novel approach for degrading target proteins. Recently, a new split-and-mix PROTAC (SM-PROTAC) system based on liposome self-assembly, known as ...
Liposomal retinol and niacinamide boost stability and skin delivery while enhancing anti-aging effects. Learn more about this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results